A Study to Evaluate Economic and Clinical Outcomes of Whole Exome Sequencing

Overview

About this study

The overall hypothesis is that the early detection of genetic variants leads to early interventions in cancer development.  This will lead to lower rates of cancer development and will eventually result in lower death rate from cancer.  In the short term, healthcare utilization and costs will increase due to the early interventions and treatments.  In the long term, benefit will start to emerge due to the lower disease development, lower death rate, and retaining of the quality of life and life expectancy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Tapestry patients who have received genetic results, regardless of positive or negative testing results.
  • Age of 18 and older.
  • Patients with an established Mayo Clinic provider prior to their enrollment in Tapestry.

Exclusion Criteria: 

  • Individuals less than 18 years old.
  • Patients without capacity to consent (i.e., needing legal authorized representatives).
  • Prisoners.
  • Subjects eligible for chart review, without a Minnesota Research Authorization on record.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Bijan Borah, Ph.D.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Ann Johnson Paramedic

Tapestry@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Niloy Jewel Samadder, M.D.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Ann Johnson Paramedic

Tapestry@mayo.edu

More information

Publications

Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions